TELA Bio (TELA) Cash from Investing Activities (2018 - 2026)
TELA Bio has reported Cash from Investing Activities over the past 8 years, most recently at $192000.0 for Q4 2025.
- For Q4 2025, Cash from Investing Activities rose 201.05% year-over-year to $192000.0; the TTM value through Dec 2025 reached $846000.0, down 80.99%, while the annual FY2025 figure was $846000.0, 80.99% down from the prior year.
- Cash from Investing Activities for Q4 2025 was $192000.0 at TELA Bio, down from $312000.0 in the prior quarter.
- Over five years, Cash from Investing Activities peaked at $4.7 million in Q1 2024 and troughed at -$1.0 million in Q4 2022.
- A 5-year average of $109950.0 and a median of -$128000.0 in 2023 define the central range for Cash from Investing Activities.
- Biggest five-year swings in Cash from Investing Activities: plummeted 1427.27% in 2022 and later soared 4183.48% in 2024.
- Year by year, Cash from Investing Activities stood at -$289000.0 in 2021, then crashed by 261.94% to -$1.0 million in 2022, then skyrocketed by 81.55% to -$193000.0 in 2023, then rose by 1.55% to -$190000.0 in 2024, then surged by 201.05% to $192000.0 in 2025.
- Business Quant data shows Cash from Investing Activities for TELA at $192000.0 in Q4 2025, $312000.0 in Q3 2025, and $204000.0 in Q2 2025.